August 1, 2018 M&A, Partnerships

Bio-Techne Corporation Completed Its Acquisition of Exosome Diagnostics, Inc.

AUGUST 01, 2018 MINNEAPOLIS, Aug.1, 2018 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its acquisition of Exosome Diagnostics, Inc. The transaction consideration includes an upfront payment of $250 million plus an additional $325 million that can be maximally earned through calendar year 2022 upon reaching certain performance milestones. With this acquisition, Minneapolis-based... Read more

June 25, 2018 M&A, Partnerships

Bio-Techne to Acquire Exosome Diagnostics, Inc.

 Download as PDF JUNE 25, 2018 MINNEAPOLIS and WALTHAM, Mass., June 25, 2018 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) announced today that it has reached agreement to acquire Exosome Diagnostics, Inc. for $250 million in cash plus contingent consideration of up to $325 million due upon the achievement of certain future milestones. The transaction is expected... Read more